{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:54:50Z","timestamp":1792446890498,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-JSV1-0006"],"award-info":[{"award-number":["ANR-11-JSV1-0006"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-JSV1-0006"],"award-info":[{"award-number":["ANR-11-JSV1-0006"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DPP20151033943"],"award-info":[{"award-number":["DPP20151033943"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aimed at identifying molecular biomarkers of inflammation-related depression in order to improve diagnosis and treatment. For this, we performed whole-genome expression profiling from peripheral blood in a naturalistic model of inflammation-associated major depressive disorder (MDD) represented by comorbid depression in obese patients. We took advantage of the marked reduction of depressive symptoms and inflammation following bariatric surgery to test the robustness of the identified biomarkers. Depression was assessed during a clinical interview using Mini-International Neuropsychiatric Interview and the 10-item, clinician-administered, Montgomery\u2013Asberg Depression Rating Scale. From a cohort of 100 massively obese patients, we selected 33 of them for transcriptomic analysis. Twenty-four of them were again analyzed 4\u201312 months after bariatric surgery. We conducted differential gene expression analyses before and after surgery in unmedicated MDD and non-depressed obese subjects. We found that TP53 (Tumor Protein 53), GR (Glucocorticoid Receptor), and NF\u03baB (Nuclear Factor kappa B) pathways were the most discriminating pathways associated with inflammation-related MDD. These signaling pathways were processed in composite\n                    <jats:italic>z<\/jats:italic>\n                    -scores of gene expression that were used as biomarkers in regression analyses. Results showed that these transcriptomic biomarkers highly predicted depressive symptom intensity at baseline and their remission after bariatric surgery. While inflammation was present in all patients, GR signaling over-activation was found only in depressed ones where it may further increase inflammatory and apoptosis pathways. In conclusion, using an original model of inflammation-related depression and its remission without antidepressants, we provide molecular predictors of inflammation-related MDD and new insights in the molecular pathways involved.\n                  <\/jats:p>","DOI":"10.1038\/s41398-021-01323-9","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T08:02:35Z","timestamp":1617696155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Transcriptomic signaling pathways involved in a naturalistic model of inflammation-related depression and its remission"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7315-5319","authenticated-orcid":false,"given":"Marie-Pierre","family":"Moisan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4552-3222","authenticated-orcid":false,"given":"Aline","family":"Foury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dexpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve W.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Beau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ledaguenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Magne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2060-5918","authenticated-orcid":false,"given":"Lucile","family":"Capuron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"1323_CR1","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","volume":"130","author":"L Capuron","year":"2011","unstructured":"Capuron, L. & Miller, A. H. Immune system to brain signaling: neuropsychopharmacological implications. Pharm. Ther. 130, 226\u2013238 (2011).","journal-title":"Pharm. Ther."},{"key":"1323_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41582-019-0174-4","volume":"15","author":"K Pape","year":"2019","unstructured":"Pape, K., Tamouza, R., Leboyer, M. & Zipp, F. Immunoneuropsychiatry\u2014novel perspectives on brain disorders. Nat. Rev. Neurol. 15, 317\u2013328 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"1323_CR3","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith, D. R., Rapaport, M. H. & Miller, B. J. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry 21, 1696\u20131709 (2016).","journal-title":"Mol. Psychiatry"},{"key":"1323_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/npp.2016.169","volume":"42","author":"J Barnes","year":"2017","unstructured":"Barnes, J., Mondelli, V. & Pariante, C. M. Genetic contributions of inflammation to depression. Neuropsychopharmacology 42, 81\u201398 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"1323_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.euroneuro.2015.06.007","volume":"25","author":"R Strawbridge","year":"2015","unstructured":"Strawbridge, R. et al. Inflammation and clinical response to treatment in depression: a meta-analysis. Eur. Neuropsychopharmacol. 25, 1532\u20131543 (2015).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1323_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-28","volume":"11","author":"N Hepgul","year":"2013","unstructured":"Hepgul, N., Cattaneo, A., Zunszain, P. A. & Pariante, C. M. Depression pathogenesis and treatment: what can we learn from blood mRNA expression? BMC Med. 11, 28 (2013).","journal-title":"BMC Med."},{"key":"1323_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.pnpbp.2015.02.008","volume":"64","author":"E Lin","year":"2016","unstructured":"Lin, E. & Tsai, S.-J. Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy. Prog. Neuropsychopharmacol. Biol. Psychiatry 64, 334\u2013340 (2016).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"1323_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41386-019-0316-9","volume":"44","author":"JH-J Cho","year":"2019","unstructured":"Cho, J. H.-J., Irwin, M. R., Eisenberger, N. I., Lamkin, D. M. & Cole, S. W. Transcriptomic predictors of inflammation-induced depressed mood. Neuropsychopharmacology 44, 923\u2013929 (2019).","journal-title":"Neuropsychopharmacology"},{"key":"1323_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fendo.2014.00074","volume":"5","author":"N Castanon","year":"2014","unstructured":"Castanon, N., Lasselin, J. & Capuron, L. Neuropsychiatric comorbidity in obesity: role of inflammatory processes. Front. Endocrinol. 5, 74 (2014).","journal-title":"Front. Endocrinol."},{"key":"1323_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.psyneuen.2018.02.030","volume":"91","author":"I Delgado","year":"2018","unstructured":"Delgado, I. et al. Depressive symptoms in obesity: relative contribution of low-grade inflammation and metabolic health. Psychoneuroendocrinology 91, 55\u201361 (2018).","journal-title":"Psychoneuroendocrinology"},{"key":"1323_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/npp.2016.123","volume":"42","author":"L Capuron","year":"2017","unstructured":"Capuron, L., Lasselin, J. & Castanon, N. Role of adiposity-driven inflammation in depressive morbidity. Neuropsychopharmacology 42, 115\u2013128 (2017).","journal-title":"Neuropsychopharmacology"},{"key":"1323_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s11695-007-9140-0","volume":"17","author":"CF Emery","year":"2007","unstructured":"Emery, C. F. et al. Gastric bypass surgery is associated with reduced inflammation and less depression: a preliminary investigation. Obes. Surg. 17, 759\u2013763 (2007).","journal-title":"Obes. Surg."},{"issue":"Suppl 20","key":"1323_CR13","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan, D. V. et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59(Suppl 20), 22\u201333 (1998).","journal-title":"J. Clin. Psychiatry"},{"key":"1323_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery, S. A. & Asberg, M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382\u2013389 (1979).","journal-title":"Br. J. Psychiatry"},{"key":"1323_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0076-6879(06)11019-8","volume":"411","author":"T Barrett","year":"2006","unstructured":"Barrett, T. & Edgar, R. Gene expression omnibus: microarray data storage, submission, retrieval, and analysis. Methods Enzymol. 411, 352\u2013369 (2006).","journal-title":"Methods Enzymol."},{"key":"1323_CR16","doi-asserted-by":"crossref","unstructured":"L\u00ea Cao, K.-A., Rossouw, D., Robert-Grani\u00e9, C., & Besse, P. A sparse PLS for variable selection when integrating omics data. Stat. Appl. Genet. Mol. Biol. 7, Article 35 (2008).","DOI":"10.2202\/1544-6115.1390"},{"key":"1323_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).","journal-title":"Genome Biol."},{"key":"1323_CR18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185\u2013193 (2003).","journal-title":"Bioinformatics"},{"key":"1323_CR19","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1198\/jasa.2009.tm08332","volume":"104","author":"C Friguet","year":"2009","unstructured":"Friguet, C., Kloareg, M. & Causeur, D. A factor model approach to multiple testing under dependence. J. Am. Stat. Assoc. 104, 1406\u20131415 (2009).","journal-title":"J. Am. Stat. Assoc."},{"key":"1323_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2202\/1544-6115.1027","volume":"3","author":"GK Smyth","year":"2004","unstructured":"Smyth, G. K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, 1\u201325 (2004).","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"1323_CR21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful. approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"1323_CR22","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1093\/bioinformatics\/btv015","volume":"31","author":"M Chikina","year":"2015","unstructured":"Chikina, M., Zaslavsky, E. & Sealfon, S. C. CellCODE: a robust latent variable approach to differential expression analysis for heterogeneous cell populations. Bioinformatics 31, 1584\u20131591 (2015).","journal-title":"Bioinformatics"},{"key":"1323_CR23","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1073\/pnas.1014218108","volume":"108","author":"SW Cole","year":"2011","unstructured":"Cole, S. W., Hawkley, L. C., Arevalo, J. M. G. & Cacioppo, J. T. Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes. Proc. Natl Acad. Sci. USA 108, 3080\u20133085 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1323_CR24","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1002\/cncr.31356","volume":"124","author":"DS Black","year":"2018","unstructured":"Black, D. S., Cole, S. W., Christodoulou, G. & Figueiredo, J. C. Genomic mechanisms of fatigue in survivors of colorectal cancer. Cancer 124, 2637\u20132644 (2018).","journal-title":"Cancer"},{"key":"1323_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen, K. E. & Hotamisligil, G. S. Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111\u20131119 (2005).","journal-title":"J. Clin. Invest."},{"key":"1323_CR26","doi-asserted-by":"publisher","first-page":"6871089","DOI":"10.1155\/2017\/6871089","volume":"2017","author":"W Liu","year":"2017","unstructured":"Liu, W. et al. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast. 2017, 6871089 (2017).","journal-title":"Neural Plast."},{"key":"1323_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/187152706778559273","volume":"5","author":"PJ Lucassen","year":"2006","unstructured":"Lucassen, P. J. et al. Stress, depression and hippocampal apoptosis. CNS Neurol. Disord. Drug Targets 5, 531\u2013546 (2006).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"1323_CR28","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/mp.2010.52","volume":"16","author":"RC Shelton","year":"2011","unstructured":"Shelton, R. C. et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol. Psychiatry 16, 751\u2013762 (2011).","journal-title":"Mol. Psychiatry"},{"key":"1323_CR29","doi-asserted-by":"publisher","first-page":"13529","DOI":"10.1073\/pnas.1401660111","volume":"111","author":"NP Daskalakis","year":"2014","unstructured":"Daskalakis, N. P., Cohen, H., Cai, G., Buxbaum, J. D. & Yehuda, R. Expression profiling associates blood and brain glucocorticoid receptor signaling with trauma-related individual differences in both sexes. Proc. Natl Acad. Sci. USA 111, 13529\u201313534 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1323_CR30","doi-asserted-by":"publisher","first-page":"223","DOI":"10.21101\/cejph.a4301","volume":"24","author":"S Mahmood","year":"2016","unstructured":"Mahmood, S., Evinov\u00e1, A., \u0160kere\u0148ov\u00e1, M., Ondrejka, I. & Lehotsk\u00fd, J. Association of EGF, IGFBP-3 and TP53 gene polymorphisms with major depressive disorder in Slovak population. Cent. Eur. J. Public Health 24, 223\u2013230 (2016).","journal-title":"Cent. Eur. J. Public Health"},{"key":"1323_CR31","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/nm.2014","volume":"15","author":"T Minamino","year":"2009","unstructured":"Minamino, T. et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15, 1082\u20131087 (2009).","journal-title":"Nat. Med."},{"key":"1323_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.psyneuen.2010.03.007","volume":"36","author":"C Anacker","year":"2011","unstructured":"Anacker, C., Zunszain, P. A., Carvalho, L. A. & Pariante, C. M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology 36, 415\u2013425 (2011).","journal-title":"Psychoneuroendocrinology"},{"key":"1323_CR33","doi-asserted-by":"publisher","first-page":"e2002690","DOI":"10.1371\/journal.pbio.2002690","volume":"15","author":"T Carrillo-Roa","year":"2017","unstructured":"Carrillo-Roa, T. et al. Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity. PLoS Biol. 15, e2002690 (2017).","journal-title":"PLoS Biol."},{"key":"1323_CR34","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1038\/tp.2013.118","volume":"4","author":"LA Carvalho","year":"2014","unstructured":"Carvalho, L. A. et al. Inflammatory activation is associated with a reduced glucocorticoid receptor alpha\/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Transl. Psychiatry 4, e344\u2013e344 (2014).","journal-title":"Transl. Psychiatry"},{"key":"1323_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2014.08.004","volume":"44","author":"L Grosse","year":"2015","unstructured":"Grosse, L. et al. Clinical characteristics of inflammation-associated depression: Monocyte gene expression is age-related in major depressive disorder. Brain Behav. Immun. 44, 48\u201356 (2015).","journal-title":"Brain Behav. Immun."},{"key":"1323_CR36","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/npp.2011.331","volume":"37","author":"A Menke","year":"2012","unstructured":"Menke, A. et al. Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology 37, 1455\u20131464 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"1323_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00874-7","volume":"10","author":"A Cattaneo","year":"2020","unstructured":"Cattaneo, A. et al. Whole-blood expression of inflammasome- and glucocorticoid-related mRNAs correctly separates treatment-resistant depressed patients from drug-free and responsive patients in the BIODEP study. Transl. Psychiatry 10, 232 (2020).","journal-title":"Transl. Psychiatry"},{"key":"1323_CR38","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/nyas.12781","volume":"1351","author":"MA Horowitz","year":"2015","unstructured":"Horowitz, M. A. & Zunszain, P. A. Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin. Ann. N. Y Acad. Sci. 1351, 68\u201379 (2015).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"1323_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbi.2009.07.008","volume":"24","author":"MG Frank","year":"2010","unstructured":"Frank, M. G., Miguel, Z. D., Watkins, L. R. & Maier, S. F. Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain Behav. Immun. 24, 19\u201330 (2010).","journal-title":"Brain Behav. Immun."},{"key":"1323_CR40","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.bbi.2020.03.012","volume":"87","author":"MA Horowitz","year":"2020","unstructured":"Horowitz, M. A. et al. Glucocorticoids prime the inflammatory response of human hippocampal cells through up-regulation of inflammatory pathways. Brain Behav. Immun. 87, 777\u2013794 (2020).","journal-title":"Brain Behav. Immun."},{"key":"1323_CR41","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1176\/appi.ajp.160.7.1342","volume":"160","author":"L Capuron","year":"2003","unstructured":"Capuron, L. et al. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am. J. Psychiatry 160, 1342\u20131345 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"1323_CR42","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1096\/fj.01-0577com","volume":"16","author":"C Crochemore","year":"2002","unstructured":"Crochemore, C., Michaelidis, T. M., Fischer, D., Loeffler, J.-P. & Almeida, O. F. X. Enhancement of p53 activity and inhibition of neural cell proliferation by glucocorticoid receptor activation. FASEB J. 16, 761\u2013770 (2002).","journal-title":"FASEB J."},{"key":"1323_CR43","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1136\/annrheumdis-2012-203146","volume":"73","author":"RC Poulsen","year":"2014","unstructured":"Poulsen, R. C. et al. Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53\/p21 pathway: in vivo and in vitro evidence. Ann. Rheum. Dis. 73, 1405\u20131413 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"1323_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2013.04.004","volume":"31","author":"D Mehta","year":"2013","unstructured":"Mehta, D. et al. Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression. Brain Behav. Immun. 31, 205\u2013215 (2013).","journal-title":"Brain Behav. Immun."},{"key":"1323_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.79","volume":"6","author":"SH Mellon","year":"2016","unstructured":"Mellon, S. H. et al. Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment. Transl. Psychiatry 6, e821 (2016).","journal-title":"Transl. Psychiatry"},{"key":"1323_CR46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bbi.2019.03.004","volume":"80","author":"JJ Chiang","year":"2019","unstructured":"Chiang, J. J. et al. Depressive symptoms and immune transcriptional profiles in late adolescents. Brain Behav. Immun. 80, 163\u2013169 (2019).","journal-title":"Brain Behav. Immun."},{"key":"1323_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.15","volume":"5","author":"K Malki","year":"2015","unstructured":"Malki, K. et al. Identification of genes and gene pathways associated with major depressive disorder by integrative brain analysis of rat and human prefrontal cortex transcriptomes. Transl. Psychiatry 5, e519 (2015).","journal-title":"Transl. Psychiatry"},{"key":"1323_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/mp.2015.57","volume":"21","author":"R Jansen","year":"2016","unstructured":"Jansen, R. et al. Gene expression in major depressive disorder. Mol. Psychiatry 21, 339\u2013347 (2016).","journal-title":"Mol. Psychiatry"},{"key":"1323_CR49","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/mp.2013.161","volume":"19","author":"S Mostafavi","year":"2014","unstructured":"Mostafavi, S. et al. Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing. Mol. Psychiatry 19, 1267\u20131274 (2014).","journal-title":"Mol. Psychiatry"},{"key":"1323_CR50","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1017\/S0033291711002868","volume":"42","author":"JC Felger","year":"2012","unstructured":"Felger, J. C. et al. Molecular signatures of peripheral blood mononuclear cells during chronic interferon-\u03b1 treatment: relationship with depression and fatigue. Psychol. Med. 42, 1591\u20131603 (2012).","journal-title":"Psychol. Med."},{"key":"1323_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbi.2012.10.007","volume":"31","author":"J Savitz","year":"2013","unstructured":"Savitz, J. et al. Inflammation and neurological disease-related genes are differentially expressed in depressed patients with mood disorders and correlate with morphometric and functional imaging abnormalities. Brain Behav. Immun. 31, 161\u2013171 (2013).","journal-title":"Brain Behav. Immun."},{"key":"1323_CR52","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.psyneuen.2010.06.008","volume":"35","author":"SW Cole","year":"2010","unstructured":"Cole, S. W. Elevating the perspective on human stress genomics. Psychoneuroendocrinology 35, 955\u2013962 (2010).","journal-title":"Psychoneuroendocrinology"},{"key":"1323_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"1323_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/bioinformatics\/bti038","volume":"21","author":"SW Cole","year":"2005","unstructured":"Cole, S. W., Yan, W., Galic, Z., Arevalo, J. & Zack, J. A. Expression-based monitoring of transcription factor activity: the \u2121iS database. Bioinformatics 21, 803\u2013810 (2005).","journal-title":"Bioinformatics"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01323-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01323-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01323-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T13:44:30Z","timestamp":1724766270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01323-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01323-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.21.20196592","asserted-by":"object"}]},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"7 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"203"}}